These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. No Bad Blood-Surviving Severe Anemia Without Transfusion. Johnson-Arbor K, Verstraete R. JAMA Intern Med; 2021 Jan 01; 181(1):7-8. PubMed ID: 33226407 [No Abstract] [Full Text] [Related]
14. [Significance of the volume of circulating blood and its components for assessing the state of patients with uterine fibromyoma at the stage of surgical treatment]. Spalek II. Pediatr Akus Ginekol; 1974 Jan 01; (2):53-5. PubMed ID: 4438026 [No Abstract] [Full Text] [Related]
15. [Systemic hemodynamics characteristics in a combination of hypertension and uterine fibromyoma]. Zaĭtseva VI, Zanozdra NS. Vrach Delo; 1980 Sep 01; (9):58-60. PubMed ID: 7423953 [No Abstract] [Full Text] [Related]
16. [Characteristics of blood rheological and coagulation properties in patients with uterine myoma]. Kirsanova MI. Akush Ginekol (Mosk); 1988 May 01; (5):14-7. PubMed ID: 3177767 [No Abstract] [Full Text] [Related]
18. [Edocrinal study of uterine fibromyoma]. Nava y Sánchez R. Ginecol Obstet Mex; 1974 Jun 01; 35(212):657-80. PubMed ID: 4138171 [No Abstract] [Full Text] [Related]
20. [Intra-abdominal hemorrhage in uterine fibromyoma]. Andrianov AV. Vestn Khir Im I I Grek; 1984 Aug 01; 133(8):74. PubMed ID: 6495530 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]